BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results

  United Therapeutics Corporation announces their highest quarterly and annual net revenues ever.

  February 21, 2018

   · 

  25 min read
• Genetown

  Cerevance Kicks Off 2018 with Additional $10 Million of Infusions

  Cerevance, a drug discovery and development company focused on brain diseases, today announced that it has received an additional equity investment as well as a non-dilutive cash payment in the first six weeks of 2018 totaling more than $10 million.

  February 21, 2018

   · 

  2 min read
• Co-Diagnostics, Inc. Ships Product to India for Validation Study

  Co-Diagnostics, Inc. announced today a product shipment to India containing tests for tuberculosis to be sold as Research Use Only as well as others to be used in validation studies.

  February 21, 2018

   · 

  3 min read
• New report shines light on disconnect between patient and physicians when it comes to the seriousness of IBS, leading to slow diagnosis

  Report investigates hidden burden of irritable bowel syndrome (IBS) on quality of life and sets out recommendations for improving care

  February 21, 2018

   · 

  10 min read
• Business

  NanoViricides Files Quarterly Report for Period Ending December 31, 2017

  NanoViricides, Inc., a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, filed its quarterly report for its second quarter of financial year 2018

  February 21, 2018

   · 

  9 min read
• Business

  AMRI Appoints Anthony L. Mattacchione to Senior Vice President and Chief Financial Officer

  AMRI, a global pharmaceutical contract research, development and manufacturing organization, today announced the appointment of Anthony Mattacchione as senior vice president and chief financial officer, effective April 2, 2018.

  February 21, 2018

   · 

  2 min read
• Pharm Country

  Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR®

  Amneal Pharmaceuticals has launched memantine hydrochloride extended-release capsules, the company’s AB-rated equivalent for Namenda XR®, in 7 mg, 14 mg, 21 mg and 28 mg strengths.

  February 21, 2018

   · 

  1 min read
• Drug Development

  Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain

  Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain

  February 21, 2018

   · 

  5 min read
• Genetown

  Charles River Laboratories Announces New Tumor Model Compendium

  Feb. 21, 2018 13:00 UTC The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies

  February 21, 2018

   · 

  3 min read
• Aldevron Announces Ready-to-Use AAV Helper Plasmid

  New plasmid to reduce cost and timeline for gene therapy manufacturing.

  February 21, 2018

   · 

  3 min read